Mia by Kheiron

Kheiron Medical's AI tool, Mia, revolutionizes breast cancer screening by enhancing detection accuracy and speed. This AI-driven system in  Healthcare  supports radiologists in making critical decisions about patient callbacks, potentially halving missed cancer cases. Proven in clinical practice, with  ai for cancer,  Mia helps detect 13% more cancers, potentially saving thousands of lives annually in the UK and US. It integrates seamlessly into existing workflows, offering reliable, timely results and empowering doctors to deliver better outcomes for patients.

• Radiologists' Support: Mia helps radiologists by flagging suspicious cases, increasing accuracy and reducing missed cancer detections. This assists in making crucial recall decisions, thus improving diagnostic confidence and patient outcomes.
• Workflow Efficiency: By automating up to 25% of the reading workflow, Mia significantly reduces the workload on radiologists, addressing staff shortages and fatigue issues prevalent in the healthcare sector.
• Cost Savings for Providers: The platform aids in standardizing processes, mitigating radiologist shortages, and offering immediate cost benefits by streamlining operations.
• Patient Benefits: Mia increases detection rates and reduces false positives, minimizing unnecessary biopsies and recall anxiety for women undergoing screening.

For information on pricing for the Mia tool by Kheiron Medical, you need to contact the company directly. Mia offers custom pricing tailored to the specific needs and scale of each healthcare provider. To get a quote, reach out to Kheiron through their website's contact page.

Peter Kecskemethy and Tobias Rijken co-founded Kheiron in 2016. They met and bonded over a shared vision that integrating advanced technology with clinical expertise could transform healthcare. Motivated by the question of how technology could help detect cancer earlier, they developed AI-enabled solutions to improve cancer detection, diagnosis, and assessment. Their work aims to enhance the lives of both patients and radiologists worldwide.



Peter Kecskemethy

Co-Founder & CEO



Tobias Rijken

Co-Founder & CTO

Kheiron Medical has secured a total of $22.3 million in funding. This financial backing supports their mission to enhance cancer detection and diagnosis through advanced technology. The funds enable continuous development and implementation of their innovative solutions in healthcare settings worldwide.